Previous studies have shown that the specificity window for MLN8237 against Aurora A and B is narrow and it varies in different tumor cell lines, making it difficult to fully inhibit Aurora A without affecting Aurora B [37]. The gene discussed is AURKB; the disease is neoplasm.